2 162

Cited 22 times in

The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings.

Authors
 S-W Lee  ;  M‐C Park  ;  S-K Lee  ;  Y-B Park 
Citation
 Lupus, Vol.21(14) : 1531-1537, 2012 
Journal Title
 Lupus 
ISSN
 0961-2033 
Issue Date
2012
MeSH
Adult ; Brain/physiopathology* ; Female ; Fluorodeoxyglucose F18 ; Humans ; Lupus Vasculitis, Central Nervous System/diagnosis* ; Lupus Vasculitis, Central Nervous System/physiopathology ; Magnetic Resonance Imaging/methods* ; Male ; Positron-Emission Tomography/methods* ; Radiopharmaceuticals
Keywords
18F-fluorodeoxyglucose positron emission tomography ; magnetic resonance imaging ; neuropsychiatric lupus
Abstract
Brain involvement in systemic lupus erythematosus (SLE) is a significant source of morbidity and mortality. Therefore, the early detection and treatment of brain involvement in SLE is of utmost importance; however, a confirmative diagnostic tool for neuropsychiatric SLE is yet to be developed. In this study, we investigated the efficacy of (18)F-FDG-PET for detection of brain involvement in patients with SLE with normal magnetic resonance imaging (MRI) findings. Twenty patients with SLE, who presented with neuropsychiatric symptoms despite normal brain MRI findings and who underwent brain (18)F-FDG-PET, were enrolled. The most common neuropsychiatric manifestation was headache (45%), followed by seizure (20%) and mood disorder (20%). (18)F-FDG-PET revealed significant glucose metabolic abnormalities in 15 of 20 patients (75%). The temporal (55%) and the occipital (55%) lobes were the most susceptible brain regions, followed by the frontal lobe (50%). However, neuropsychiatric symptoms were not geographically correlated to (18)F-FDG-PET findings. Two patients with abnormal (18)F-FDG-PET findings underwent follow-up brain (18)F-FDG-PET after remission, which showed complete resolution of abnormal glucose metabolism. Our data suggest that (18)F-FDG-PET may be an additional diagnostic modality complementary to MRI, when MRI is unable to provide evidence of brain involvement in patients with SLE.
Full Text
http://lup.sagepub.com/content/21/14/1531
DOI
22941565
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Park, Min Chan(박민찬) ORCID logo https://orcid.org/0000-0003-1189-7637
Park, Yong Beom(박용범)
Lee, Sang Won(이상원) ORCID logo https://orcid.org/0000-0002-8038-3341
Lee, Soo Kon(이수곤)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/91426
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse